Prevalence of xerostomia in women during breast cancer chemotherapy

ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients.

Saved in:
Bibliographic Details
Main Authors: Pinto,Vânia Lopes, Fustinoni,Suzete Maria, Nazário,Afonso Celso Pinto, Facina,Gil, Elias,Simone
Format: Digital revista
Language:English
Published: Associação Brasileira de Enfermagem 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-71672020001600189
record_format ojs
spelling oai:scielo:S0034-716720200016001892020-09-17Prevalence of xerostomia in women during breast cancer chemotherapyPinto,Vânia LopesFustinoni,Suzete MariaNazário,Afonso Celso PintoFacina,GilElias,Simone Xerostomia Breast Neoplasms Drug Therapy Women Antineoplastic Agents ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients.info:eu-repo/semantics/openAccessAssociação Brasileira de EnfermagemRevista Brasileira de Enfermagem v.73 suppl.4 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189en10.1590/0034-7167-2019-0785
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pinto,Vânia Lopes
Fustinoni,Suzete Maria
Nazário,Afonso Celso Pinto
Facina,Gil
Elias,Simone
spellingShingle Pinto,Vânia Lopes
Fustinoni,Suzete Maria
Nazário,Afonso Celso Pinto
Facina,Gil
Elias,Simone
Prevalence of xerostomia in women during breast cancer chemotherapy
author_facet Pinto,Vânia Lopes
Fustinoni,Suzete Maria
Nazário,Afonso Celso Pinto
Facina,Gil
Elias,Simone
author_sort Pinto,Vânia Lopes
title Prevalence of xerostomia in women during breast cancer chemotherapy
title_short Prevalence of xerostomia in women during breast cancer chemotherapy
title_full Prevalence of xerostomia in women during breast cancer chemotherapy
title_fullStr Prevalence of xerostomia in women during breast cancer chemotherapy
title_full_unstemmed Prevalence of xerostomia in women during breast cancer chemotherapy
title_sort prevalence of xerostomia in women during breast cancer chemotherapy
description ABSTRACT Objective: To identify the prevalence of xerostomia in women undergoing chemotherapy for breast cancer. Method: Prospective cohort with 27 women who underwent up to 16 sessions of intravenous chemotherapy. Data collection was performed at the outpatient clinic of a university hospital in the city of São Paulo, where two forms were applied before the start of treatment and the Xerostomia Inventory before and after each chemotherapy session. Results: Complaints of dry mouth were present in 48.1% of women before chemotherapy, and they were approximately 28 times more likely to develop dry mouth during treatment. It was observed that the use of antiemetics contributed to the occurrence of xerostomia, and the anti-ulcerous were presented as a protective factor. Conclusion: The study identified both a high prevalence of xerostomia regardless of the chemotherapy used and the need to create protocols to improve the quality of life of these patients.
publisher Associação Brasileira de Enfermagem
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672020001600189
work_keys_str_mv AT pintovanialopes prevalenceofxerostomiainwomenduringbreastcancerchemotherapy
AT fustinonisuzetemaria prevalenceofxerostomiainwomenduringbreastcancerchemotherapy
AT nazarioafonsocelsopinto prevalenceofxerostomiainwomenduringbreastcancerchemotherapy
AT facinagil prevalenceofxerostomiainwomenduringbreastcancerchemotherapy
AT eliassimone prevalenceofxerostomiainwomenduringbreastcancerchemotherapy
_version_ 1756377244632088576